84bd90f5-4a1f-42a8-8eb1-5cb062a0b6ac.png
Opioids Market to Soar to USD 29.5 Billion by 2033 | Driven by Chronic Pain Prevalence and Increasing Surgical Procedures
February 13, 2024 07:23 ET | Market.Us
New York, Feb. 13, 2024 (GLOBE NEWSWIRE) -- According to Market.us, the Global Opioids Market size is projected to exceed USD 29.5 Billion by 2033, with a promising CAGR of 2.9% from 2024 to 2033. ...
Logo.png
Chronic Pain Market is Expected to Showcase a Significant Growth by 2032, Predicts DelveInsight | Key Players - Paradigm Biopharmaceuticals, Noven Pharmaceuticals, Pfizer, Biogen, Tonix Pharmaceuticals, Amzell, Bayer, and Others
February 07, 2024 13:00 ET | DelveInsight Business Research LLP
New York, USA, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Chronic Pain Market is Expected to Showcase a Significant Growth by 2032, Predicts DelveInsight | Key Players - Paradigm Biopharmaceuticals, Noven...
logo.png
Silo Pharma Announces Pipeline Prioritization for 2024 Targeting Mental Health, Chronic Pain, and Neurology
February 01, 2024 10:00 ET | Silo Pharma, Inc.
Preparing Pre-Investigational New Drug Application for lead drug program SPC-15 Company plans to pursue FDA streamlined 505(b)(2) pathway for clinical drug development SARASOTA, FL, Feb. 01,...
Fibromyalgia Treatment Market Projected to Surpass US$ 2.7 Billion in Revenue by 2033, According to Persistence Market Research
January 18, 2024 09:45 ET | Persistence Market Research
New York, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Market Overview: The global revenue from the fibromyalgia treatment market stands at US$ 1.3 billion in 2022, with the global market expected to grow...
Curonix-PrimaryLogo_CMYK.png
Curonix Partners with Sure Med Compliance to Expand PNS Clinical Evidence
January 18, 2024 08:00 ET | Curonix LLC
Curonix Partners with Sure Med Compliance to Expand PNS Clinical Evidence
Patient-controlled Analgesic Pumps Market Poised to Hit Striking US$ 712 Million Valuation by 2033 | Persistence Market Research
January 11, 2024 07:00 ET | Persistence Market Research
New York, Jan. 11, 2024 (GLOBE NEWSWIRE) -- Market Overview: The Patient-controlled Analgesic Pumps Market is a segment within the broader medical device industry, primarily focused on providing...
Research Nester Logo.jpg
Digital Biomarkers Market revenue to hit USD 83.8 Billion by 2035, says Research Nester
December 05, 2023 06:00 ET | Research Nester
New York , Dec. 05, 2023 (GLOBE NEWSWIRE) -- The global digital biomarkers market size is expected to expand at 32.15% CAGR from 2023 to 2035. The market is anticipated to garner a revenue of USD...
Curonix-PrimaryLogo_CMYK.png
Curonix Celebrates 1st Anniversary
November 01, 2023 09:00 ET | Curonix LLC
POMPANO BEACH, Fla., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Today, Curonix LLC, a leading peripheral nerve stimulation company celebrated its first anniversary. In November 2022, Curonix completed the...
AMR Logo.png
Neuromodulation Market is Projected to Gain $4,342.50 Million by 2030, Claims Allied Market Research  
October 31, 2023 09:30 ET | Allied Market Research
Wilmington, Delaware, Oct. 31, 2023 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global neuromodulation market to generate $4,342.50 million by 2030,...
EC-Logo-2018_TM_CMYK.jpg
gammaCore Non-Invasive Vagus Nerve Stimulation (nVNS) Improves Attention and Working Memory in Patients with Post Traumatic Stress Disorder (PTSD)
September 27, 2023 08:00 ET | electroCore, Inc.
ROCKAWAY, N.J., Sept. 27, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced the publication of two peer...